Insight Capital is a venture capital firm based in Beijing, China, established in 2016. The firm specializes in early-stage investments, primarily targeting the health and biotechnology sectors. Insight Capital focuses on areas such as biotechnology, medical equipment, medical services, biomedicine, and the research and development of new drugs. The firm aims to support innovations in these fields, contributing to advancements in medical treatments and mobile healthcare solutions.
Iongen Therepeutics is an innovative drug research and development company focusing on pain treatment.
Sigma Squares Tech
Series B in 2024
Sigma Squares Tech focuses on developing automated manufacturing systems and industrial automation solutions. The company specializes in computer vision technologies and offers cloud-based platforms that analyze significant volumes of industrial data during the manufacturing process. By providing integrated analytical and control solutions, Sigma Squares Tech aims to enhance the efficiency and intelligence of small and medium-sized manufacturing companies.
Sieran Medical
Seed Round in 2024
Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
Amity
Series C in 2024
Amity is a technology holding and investment company that focuses on enhancing customer experience through AI-driven solutions. Its portfolio includes several companies, such as Amity Solutions, which specializes in employee engagement through chatbots and AI platforms. Another key component of Amity's business is its online social platform, designed to improve communication and collaboration among organizations, teams, and individuals. This platform facilitates project collaboration, enables the sharing of e-forms and reports, and ultimately aims to create more efficient and productive teams, thereby optimizing customer experiences across various corporate environments.
LeadBio Tech
Series A in 2023
LeadBio Tech is a biotechnology company focused on creating bioartificial blood vessel medical devices. The company specializes in tissue engineering and tissue regeneration solutions aimed at replacing and repairing human tissues and organs. LeadBio Tech develops degradable bioartificial blood vessels utilizing innovative skeleton immune wrapping technology. These products are primarily designed for use in arteriovenous graft surgeries, offering advanced artificial vessel solutions to enhance patient care and outcomes.
Yaoshi Medical
Series A in 2023
Yaoshi Medical conducts research and development in the field of ocular illness diagnosis and screening equipment.
Phil Rivers Technology
Series A in 2022
Phil Rivers Technologies provides a platform for medical innovation by merging biotechnology and information technology. Phil Rivers Technology's world-class digital twin technology can provide oncology medication targets in a systematic manner, precisely locate applicable indications, and properly forecast responders to therapy.
Jingwei Shida
Series A in 2022
Jingwei Shida is a medical equipment R&D and supplier, focusing on the research and development of optoelectronic medical equipment.
Ashermed
Series B in 2022
Ashermed is a provider of contract research organization (CRO) services tailored for medical companies. The company emphasizes the integration of advanced technologies, including Internet technology, big data, and artificial intelligence, into its offerings. By doing so, Ashermed aims to help medical companies shorten the drug development cycle, enhance the quality of clinical data, and lower research and development costs. Their services encompass CRO, site management organization (SMO), patient recruitment, and digital platform support, positioning them as a comprehensive partner in the medical research industry.
Pulse Medical Technology
Series C in 2021
Pulse Medical Technology develops innovative technology for the diagnosis and optimal treatment of pan-vascular diseases.
Sigma Squares Tech
Series A in 2021
Sigma Squares Tech focuses on developing automated manufacturing systems and industrial automation solutions. The company specializes in computer vision technologies and offers cloud-based platforms that analyze significant volumes of industrial data during the manufacturing process. By providing integrated analytical and control solutions, Sigma Squares Tech aims to enhance the efficiency and intelligence of small and medium-sized manufacturing companies.
Saturnbird Coffee
Series B in 2021
SaturnBird Coffee Co., Ltd, founded in 2011 and based in Changsha, China, operates coffee shops and offers a range of coffee products, including instant coffee. The company is known for its unique brewing technology, which aims to preserve the original flavor and aroma of coffee beans. SaturnBird's instant coffee powder can be dissolved in various liquids, including hot and cold water, milk, and oat milk, allowing for versatile coffee preparation. The cafes are designed to enhance the coffee drinking experience through thoughtful selection of utensils and interior design, creating an inviting atmosphere for customers. SaturnBird Coffee aims to provide a high-quality coffee experience that caters to diverse preferences and settings.
Dearer Medical
Series B in 2021
Dearer Medical is a medical device company based in China that specializes in the development, production, and sales of eye-related products, particularly contact lenses. The company emphasizes research and development to create both practical and fashionable color contact lenses, catering to a diverse customer base. Through its innovative approach, Dearer Medical aims to enhance the user experience while addressing the aesthetic and functional needs of contact lens wearers.
LeadBio Tech
Seed Round in 2021
LeadBio Tech is a biotechnology company focused on creating bioartificial blood vessel medical devices. The company specializes in tissue engineering and tissue regeneration solutions aimed at replacing and repairing human tissues and organs. LeadBio Tech develops degradable bioartificial blood vessels utilizing innovative skeleton immune wrapping technology. These products are primarily designed for use in arteriovenous graft surgeries, offering advanced artificial vessel solutions to enhance patient care and outcomes.
Ashermed
Series A in 2021
Ashermed is a provider of contract research organization (CRO) services tailored for medical companies. The company emphasizes the integration of advanced technologies, including Internet technology, big data, and artificial intelligence, into its offerings. By doing so, Ashermed aims to help medical companies shorten the drug development cycle, enhance the quality of clinical data, and lower research and development costs. Their services encompass CRO, site management organization (SMO), patient recruitment, and digital platform support, positioning them as a comprehensive partner in the medical research industry.
Delta Medical
Series D in 2020
Beijing Delta Medical Co., Ltd. specializes in the design and manufacture of orthopedic surgical instruments and rehabilitation products. The company offers a range of products, including shoulder arthroscopic instruments, various types of suture anchors, instruments for anterior and posterior cruciate ligament reconstruction, interference screws, and shaver systems. In addition to its surgical instruments, Delta Medical provides sports rehabilitation services. The company is headquartered in Beijing, China, and focuses on delivering innovative solutions in sports medicine.
Delta Medical
Series C in 2019
Beijing Delta Medical Co., Ltd. specializes in the design and manufacture of orthopedic surgical instruments and rehabilitation products. The company offers a range of products, including shoulder arthroscopic instruments, various types of suture anchors, instruments for anterior and posterior cruciate ligament reconstruction, interference screws, and shaver systems. In addition to its surgical instruments, Delta Medical provides sports rehabilitation services. The company is headquartered in Beijing, China, and focuses on delivering innovative solutions in sports medicine.
Ingcare Technology
Series A in 2019
Ingcare is a Beijing-based platform dedicated to providing autism recovery services and educational resources for children with autism. It operates as a comprehensive service platform that combines online and offline support, focusing on rehabilitation education. Ingcare is an innovative project incubated by Tsinghua X-lab, aiming to enhance the well-being and development of children on the autism spectrum through tailored programs and resources.
HaoYunBang
Series C in 2018
Haoyunbang is a comprehensive medical resource center focused on providing fertility care for women. The company operates both mobile applications and physical clinics, offering personalized prenatal guidance and counseling. This dual approach allows women to manage their pregnancies more conveniently while receiving professional care tailored to their individual needs. By integrating technology with in-person services, Haoyunbang aims to enhance the overall pregnancy experience for its patients.
Ackerman Boitech
Series A in 2018
Ackerman Boitech offers routine pathology, pathology consultation, DNA testing, research service, clinical reading, offline film reading, pathology consultation, teleconsultation, and more. In addition, they also provide molecular pathology detection and diagnosis. The company's contact mode is at its physical address.
Aitekang Medical
Series B in 2018
Beijing Aitekang Medical Technology Co., Ltd. is a healthcare company founded in 2004 and located in Beijing, China. It specializes in the manufacture and sale of medical devices, focusing on the development of biological hemostatic materials and wound closure devices aimed at minimally invasive surgeries. One of its notable products is Healsoon, which contributes to the company's portfolio of innovative solutions in the medical field.
Flower Bud
Series A in 2018
Flower Bud is a dental clinic that focuses on children's oral health.
OptoMedic
Series A in 2016
OptoMedic specializes in the research, development, and production of advanced optical medical devices and systems. The company focuses on creating medical fluorescence navigation endoscopes that utilize aerospace and military optical technology for applications in healthcare. Its product offerings include endoscopic monitoring equipment, cancer screening tools, endoscopic navigation systems, and fluorescent imaging systems. These innovations enable medical institutions and healthcare providers to effectively observe and assess patient conditions, enhancing diagnostic capabilities and treatment outcomes.
Aitekang Medical
Series A in 2016
Beijing Aitekang Medical Technology Co., Ltd. is a healthcare company founded in 2004 and located in Beijing, China. It specializes in the manufacture and sale of medical devices, focusing on the development of biological hemostatic materials and wound closure devices aimed at minimally invasive surgeries. One of its notable products is Healsoon, which contributes to the company's portfolio of innovative solutions in the medical field.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.